News
News
- CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019
09/17/2019 / 13:00 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/13/2019 / 16:15 - GlobeNewswire - Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS)
09/11/2019 / 22:30 - GlobeNewswire - ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/11/2019 / 15:28 - GlobeNewswire - World Point-of-Care Testing Industry Report 2019-2022 - Opportunities Presented by Physical Robotic Telepresence & Smart Virtual Assistant in Association with Mobile Devices
09/05/2019 / 13:54 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/04/2019 / 20:10 - GlobeNewswire - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/04/2019 / 17:30 - GlobeNewswire - Analysis on the North American Insulin Pens Market, 2019-2027 - Development of Cost-efficient Pen Needles Trigger Lucrative Opportunities
09/02/2019 / 17:20 - GlobeNewswire - Global Infusion Pump Software Market to 2027: Analysis of Current & Future Market Trends to Identify Investment Opportunities
09/02/2019 / 11:49 - GlobeNewswire - ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
08/27/2019 / 18:03 - GlobeNewswire
Real-time